Literature DB >> 15863912

Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice.

Minpei Kuroda, Yoshihiro Mimaki, Tozo Nishiyama, Tatsumasa Mae, Hideyuki Kishida, Misuzu Tsukagawa, Kazuma Takahashi, Teruo Kawada, Kaku Nakagawa, Mikio Kitahara.   

Abstract

The turmeric (Curcuma longa L. rhizomes) EtOH extract significantly suppressed an increase in blood glucose level in type 2 diabetic KK-A(y) mice. In an in vitro evaluation, the extract stimulated human adipocyte differentiation in a dose-dependent manner and showed human peroxisome proliferator-activated receptor (PPAR)-gamma ligand-binding activity in a GAL4-PPAR-gamma chimera assay. The main constituents of the extract were identified as curcumin, demethoxycurcumin, bisdemethoxycurcumin, and ar-turmerone, which had also PPAR-gamma ligand-binding activity. These results indicate that turmeric is a promising ingredient of functional food for the prevention and/or amelioration of type 2 diabetes and that curcumin, demethoxycurcumin, bisdemethoxycurcumin, and ar-turmerone mainly contribute to the effects via PPAR-gamma activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863912     DOI: 10.1248/bpb.28.937

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  31 in total

1.  Hypoglycemic effects of clove (Syzygium aromaticum flower buds) on genetically diabetic KK-Ay mice and identification of the active ingredients.

Authors:  Minpei Kuroda; Yoshihiro Mimaki; Takayuki Ohtomo; Junji Yamada; Tozo Nishiyama; Tatsumasa Mae; Hideyuki Kishida; Teruo Kawada
Journal:  J Nat Med       Date:  2011-10-11       Impact factor: 2.343

Review 2.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 3.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

4.  Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma-LXRalpha-ABCA1 passway.

Authors:  Shao-zhuang Dong; Shui-ping Zhao; Zhi-hong Wu; Jun Yang; Xiang-zhu Xie; Bi-lian Yu; Sai Nie
Journal:  Mol Cell Biochem       Date:  2011-07-12       Impact factor: 3.396

Review 5.  Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.

Authors:  Bharat B Aggarwal
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

6.  Curcumin-functionalized silk materials for enhancing adipogenic differentiation of bone marrow-derived human mesenchymal stem cells.

Authors:  Chunmei Li; Tingting Luo; Zhaozhu Zheng; Amanda R Murphy; Xiaoqin Wang; David L Kaplan
Journal:  Acta Biomater       Date:  2014-08-15       Impact factor: 8.947

7.  Effect of Curcumin on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review of Randomized Clinical Trials.

Authors:  Atena Mahdavi; Sajjad Moradi; Gholamreza Askari; Bijan Iraj; Thozhukat Sathyapalan; Paul C Guest; Mohammad Bagherniya; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

9.  Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ

Authors:  Venkata R Narala; Monica R Smith; Ravi K Adapala; Rajesh Ranga; Kalpana Panati; Bethany B Moore; Todd Leff; Vudem D Reddy; Anand K Kondapi; Raju C Reddy
Journal:  Gene Ther Mol Biol       Date:  2009-04-01

Review 10.  Indian Traditional medicinal plants as a source of potent Anti-diabetic agents: A Review.

Authors:  Vishakha Parab Gaonkar; Kirankumar Hullatti
Journal:  J Diabetes Metab Disord       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.